Beauty

Shiseido to sell Aupres-owner SLC to IDG-led investor group

The Japanese cosmetics group will transfer full ownership of Shiseido Liyuan Cosmetics and its Beijing factory while providing transitional IP and supply support.

Anushka RaoNovember 19, 20265 min read4 views
An unlabeled skincare bottle and cream jar stand before a stylized cosmetics factory, shipping cartons and an abstract digital-retail grid, suggesting a China beauty-business ownership transfer.

Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor consortium led by Hong Kong-based private equity firm IDG Capital. SLC makes and sells the Aupres brand in China, and the transaction covers the entire company.

The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China. Shiseido did not disclose the financial terms.

Why Shiseido is divesting SLC

Shiseido framed the sale as part of its 2030 Medium-Term Strategy, which aims to improve profitability and capital efficiency. The group said it wants to direct management resources toward areas where it has its strongest competitive advantage and concentrate on priority brands and higher-growth opportunities.

The company said SLC requires continued investment in product innovation and digital capabilities. Selling the business, according to Shiseido, allows the group to focus on brands and opportunities with stronger growth prospects.

Shiseido also described China as a strategically important and attractive market, while noting that the competitive landscape is changing rapidly. It cited the expansion of e-commerce, shifting consumer behavior and the emergence of diverse market participants as forces reshaping the sector.

Joint-venture history and deal structure

SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group, which is owned by the Beijing Municipal Government. SLC has sold the C-beauty brand Aupres since 1994.

The existing joint-venture agreement is due to expire in December 2026, and the parties agreed not to renew it. Before the sale, Shiseido acquired Beijing Liyuan's 35% stake on September 1, 2026, giving it full ownership of SLC.

Under the transaction, funds managed by IDG Capital will take 95% of the equity through two special purpose vehicles. A limited partnership enterprise set up mainly by SLC's new management team will hold the remaining 5%.

The deal includes SLC's Beijing factory and production equipment. Shiseido said it believes independent operation under IDG will support SLC's sustainable growth and brand value.

Transitional support and IP licensing

To ensure a smooth handover, Shiseido will license the intellectual property rights that IDG needs to run the business. For a specified period after the transfer, Shiseido will also provide support on new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products.

Shiseido said the transitional collaboration is intended to maintain SLC's innovation capabilities, product quality and business continuity.

Profit recovery backdrop

The divestment comes days after Shiseido reported a 124.3% increase in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). The company attributed the recovery to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales grew 0.7%.

Shiseido raised its full-year core operating profit forecast from ¥59 billion (US$433 million) to ¥87 billion (US$546 million) on the back of those results.